Marshall, G M <br/><br/>
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.  [electronic resource] 

 -  Oncogene  Nov 2010 
 - 6172-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2010.340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Differentiation<br/>Cell Movement<br/>Cell Nucleus--metabolism<br/>Cytoplasm--metabolism<br/>DNA-Binding Proteins--physiology<br/>E2F1 Transcription Factor--antagonists & inhibitors<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Neuroblastoma--pathology<br/>Transcription Factors--physiology<br/>Tripartite Motif Proteins<br/>Tumor Suppressor Proteins--physiology<br/>Ubiquitin-Protein Ligases<br/>Vimentin--antagonists & inhibitors